Genetic Trigger For Type-1 Diabetes May Act In The Lung, Liggins Study Shows
A major genetic trigger for type-1 diabetes may act in the lung, according to researchers at the Liggins Institute at the University of Auckland
Their research suggests lung infections could trigger the onset of type-1 diabetes, the auto-immune condition that leaves a person unable to produce enough insulin to keep their blood sugar in a normal range.
Hunting for patterns in vast databases of genomic data, scientists led by Professor Justin O’Sullivan used machine learning to rank genetic mutations associated with type-1 diabetes according to the size of their disease effects acting through different tissues in the body.
This resulted in the unexpected finding that the biggest impacts occurred to genes in the lung.
Their study, just published in the journal Communications Biology, is the first to uncover the link.
“Everyone knows that the pancreas is key in diabetes, because that’s the organ that makes insulin,” says Professor O’Sullivan. “But what’s really striking is that the mutations that are linked to the biggest risk of developing the disease affect genes in another tissue entirely – in the lung.
The results support a theory that respiratory viral infections can trigger the onset of type-1 diabetes. If the theory proves correct, drugs could be developed to target the key genes and slow the onset of the disease.
“It’s really a tantalising piece of information,” says Professor O’Sullivan. “This looks like a very important connection. Could we someday see a vaccine that protects some people against developing type-1 diabetes? That would be amazing.”
PhD students Daniel Ho and Denis Nyaga were key researchers on the project. Daniel developed the machine-learning approach that looked for patterns in millions of pieces of genetic data from thousands of individuals, with and without type-1 diabetes.
“The machine learning enabled us to pull patterns out of the DNA together with related biological information from thousands of people, that we couldn’t detect any other way because there is just too much data for us to look at,” says Daniel Ho.
Diabetes is surging globally, proving to be one of the major health challenges of the 21st century.
In New Zealand type-1 diabetes accounts for five to eight percent of all diabetes diagnoses, affecting as many as 26,000 people. Often discovered in childhood, the condition requires people to take insulin every day. There’s no cure, but effective management of blood sugar levels can limit complications such as heart disease, stroke, and sight problems.
Scientists already know of genetic variants that make people more likely to develop type-1 diabetes.
Researchers sequencing part of a child’s DNA at birth can use 67 genetic variants to predict with more than 90 percent accuracy whether the child will develop type-1 diabetes by age five. However, they’re still trying to figure out why, what variants play the biggest roles, and how to stop the disease from progressing.
The genetic data for the research came from the Wellcome Trust Case Control Consortium in the UK, which facilitates genome-wide association studies, and the UK Biobank containing biomedical data from half a million people. The work was funded by a donation from Sir Colin Giltrap and the Ministry of Business, Innovation and Employment.
The paper is entitled “Identifying the lungs as a susceptible site for allele-specific regulatory changes associated with type-1 diabetes risk.”